US2019201395A1PendingUtilityA1

Sleep improving agent

Assignee: AMINO UP CHEMICAL CO LTDPriority: May 26, 2016Filed: May 26, 2017Published: Jul 4, 2019
Est. expiryMay 26, 2036(~9.8 yrs left)· nominal 20-yr term from priority
A61K 31/4985A61P 25/22A61P 25/20A23V 2002/00A23L 33/10A23V 2250/30A61P 25/00A23V 2200/322
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a heat shock protein expression-inducing agent, more specifically, a heat shock protein expression-inducing agent comprising a compound represented by formula (I): wherein R is a lower alkyl, phenyl, or hydroxyphenyl, or a salt thereof.

Claims

exact text as granted — not AI-modified
1 . A heat shock protein expression-inducing agent comprising a compound represented by formula (I): 
       
         
           
           
               
               
           
         
         wherein R is a lower alkyl, phenyl, or hydroxyphenyl, 
         or a salt thereof. 
       
     
     
         2 . The heat shock protein expression-inducing agent according to  claim 1 , wherein R is isopropyl, phenyl, or hydroxyphenyl. 
     
     
         3 . The heat shock protein expression-inducing agent according to  claim 1 , wherein R is isopropyl. 
     
     
         4 . The heat shock protein expression-inducing agent according to  claim 1 , which is in the form of a pharmaceutical composition, quasi-drug composition or food and beverage composition. 
     
     
         5 . A sleep improving agent comprising a compound represented by formula (I): 
       
         
           
           
               
               
           
         
         wherein R is a lower alkyl, phenyl, or hydroxyphenyl, 
         or a salt thereof. 
       
     
     
         6 . The sleep improving agent according to  claim 5 , wherein R is isopropyl, phenyl, or hydroxyphenyl. 
     
     
         7 . The sleep improving agent according to  claim 5 , wherein R is isopropyl. 
     
     
         8 . The sleep improving agent according to  claim 5 , which is in the form of a pharmaceutical composition, quasi-drug composition or food and beverage composition. 
     
     
         9 . An autonomic nerve-adjusting agent comprising a compound represented by formula (I): 
       
         
           
           
               
               
           
         
         wherein R is a lower alkyl, phenyl, or hydroxyphenyl, 
         or a salt thereof. 
       
     
     
         10 . The autonomic nerve-adjusting agent according to  claim 9 , wherein R is isopropyl, phenyl, or hydroxyphenyl. 
     
     
         11 . The autonomic nerve-adjusting agent according to  claim 9 , wherein R is isopropyl. 
     
     
         12 . The autonomic nerve-adjusting agent according to  claim 9 , which is in the form of a pharmaceutical composition, quasi-drug composition or food and beverage composition. 
     
     
         13 . An anti-stress agent comprising a compound represented by formula (I): 
       
         
           
           
               
               
           
         
         wherein R is a lower alkyl, phenyl, or hydroxyphenyl, 
         or a salt thereof. 
       
     
     
         14 . The anti-stress agent according to  claim 13 , wherein R is isopropyl, phenyl, or hydroxyphenyl. 
     
     
         15 . The anti-stress agent according to  claim 13 , wherein R is isopropyl. 
     
     
         16 . The anti-stress agent according to  claim 13 , which is in the form of a pharmaceutical composition, quasi-drug composition or food and beverage composition.

Join the waitlist — get patent alerts

Track US2019201395A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.